12-132621242-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_170682.4(P2RX2):c.906-13G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_170682.4 intron
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 41Inheritance: AD Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
 - nonsyndromic genetic hearing lossInheritance: AD Classification: MODERATE Submitted by: ClinGen
 - autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152104Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.0000119  AC: 3AN: 251200 AF XY:  0.0000147   show subpopulations 
GnomAD4 exome  AF:  0.00000684  AC: 10AN: 1461724Hom.:  0  Cov.: 34 AF XY:  0.00000825  AC XY: 6AN XY: 727156 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152104Hom.:  0  Cov.: 31 AF XY:  0.0000269  AC XY: 2AN XY: 74300 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
Variant classified as Uncertain Significance - Favor Benign. The c.906-13G>A var iant in P2RX2 has not been previously reported in individuals with hearing loss, but has been identified in 2/8652 of East Asian chromosomes by the Exome Aggreg ation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs757748091). Alth ough this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant is located in the 3' spl ice region. Computational tools do not suggest an impact to splicing. However, t his information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the c.906-13G>A variant is uncertain, these d ata suggest that it is more likely to be benign. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at